These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3398000)

  • 21. [Preparation and characterization of prodrugs of the potential schistosomicid praziquantel].
    Riera de Narváez AJ; Araujo S
    Acta Cient Venez; 1988; 39(5-6):451-6. PubMed ID: 3270297
    [No Abstract]   [Full Text] [Related]  

  • 22. [A human strain of Schistosoma mansoni resistant to schistosomicides].
    Dias LC; Pedro RJ; Rigo E; Goto MM; Mafra GL
    Rev Saude Publica; 1978 Mar; 12(1):110. PubMed ID: 675134
    [No Abstract]   [Full Text] [Related]  

  • 23. Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Mol Biochem Parasitol; 1988 Oct; 31(1):87-96. PubMed ID: 3185615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake of [14C]oxamniquine by Schistosoma mansoni.
    Woolhouse NM; Kaye B
    Parasitology; 1977 Aug; 75(1):111-8. PubMed ID: 593728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study on the genetic effects of hycanthone and oxamniquine.
    Ray VA; Holden HE; Ellis JH; Hyneck ML
    J Toxicol Environ Health; 1975 Nov; 1(2):211-7. PubMed ID: 1107579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic and molecular aspects of drug resistance in Schistosoma mansoni].
    Pica L; Cioli D
    Ann Ist Super Sanita; 1986; 22(1):153-5. PubMed ID: 3752792
    [No Abstract]   [Full Text] [Related]  

  • 27. Schistosoma mansoni: structural damage after treatment with oxamniquine.
    Magalhães Filho A; de Melo ME; Padovan PA; Padovan IP
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():347-52. PubMed ID: 3509191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of variation in the susceptibility of Schistosoma mansoni to the antischistosomal drug oxamniquine.
    Kinoti GK
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():151-6. PubMed ID: 3509180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversibility of drug-induced regression in female Schistosoma mansoni upon pairing with male worms in vivo.
    Popiel I; Cioli D; Erasmus DA
    Z Parasitenkd; 1984; 70(3):421-4. PubMed ID: 6741226
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and antischistosomal and antitumor activity of hycanthone and some of its congeners. Evidence for the mode of action of hycanthone.
    Archer S; Pica-Mattoccia L; Cioli D; Seyed-Mozaffari A; Zayed AH
    J Med Chem; 1988 Jan; 31(1):254-60. PubMed ID: 3336024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxamniquine in the prevention of bilharzial infection.
    Jewsbury JM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):18-20. PubMed ID: 606372
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
    Jansma WB; Rogers SH; Liu CL; Bueding E
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission and scanning electron microscopical studies in the tegument of male Schistosoma mansoni after oxamniquine treatment.
    Kohn A; López-Alvarez ML; Katz N
    Ann Parasitol Hum Comp; 1982; 57(3):285-91. PubMed ID: 7137803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary laboratory trials with oxamniquine as a prophylactic agent in schistosomiasis.
    Pellegrino J; Pereira LH; Mello RT
    Rev Inst Med Trop Sao Paulo; 1976; 18(2):97-101. PubMed ID: 1273410
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo cercaria-schistosomulum transformation: inhibitory effect of oxamniquine.
    Melo AL; Pereira LH; Corrêa CR
    Trans R Soc Trop Med Hyg; 1978; 72(2):158-9. PubMed ID: 653787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hycanthone administered in vivo upon the incorporation of radioactive precursors into macromolecules of Schistosoma mansoni.
    Pica Mattoccia L; Cioli D
    Mol Biochem Parasitol; 1983 Jun; 8(2):99-107. PubMed ID: 6192338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
    Rugel AR; Guzman MA; Taylor AB; Chevalier FD; Tarpley RS; McHardy SF; Cao X; Holloway SP; Anderson TJC; Hart PJ; LoVerde PT
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():8-15. PubMed ID: 32315953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensibility of different larval stages of Schistosoma mansoni to the larvae disappearing reaction (LDR) in murine schistosomiasis (1).
    de Melo AL; Pereira LH; Chamone M
    Rev Inst Med Trop Sao Paulo; 1986; 28(6):395-9. PubMed ID: 3110909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.